Preface to Special Issue on ‘Cytochrome P450 Variation in Pharmacogenomics’
Conflicts of Interest
References
- Pikuleva, I.A.; Waterman, M.R. Cytochromes p450: Roles in diseases. J. Biol. Chem. 2013, 288, 17091–17098. [Google Scholar] [CrossRef] [PubMed]
- Zhou, Y.; Ingelman-Sundberg, M.; Lauschke, V.M. Worldwide distribution of cytochrome P450 alleles: A meta-analysis of population-scale sequencing projects. Clin. Pharmacol. Ther. 2017, 102, 688–700. [Google Scholar] [CrossRef] [PubMed]
- Gaedigk, A.; Ingelman-Sundberg, M.; Miller, N.A.; Leeder, J.S.; Whirl-Carrillo, M.; Klein, T.E.; PharmVar Steering Committee. The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the human cytochrome P450 (CYP) allele nomenclature database. Clin. Pharmacol. Ther. 2018, 103, 399–401. [Google Scholar] [CrossRef] [PubMed]
- Tanner, J.-A.; Tyndale, R.F. Variation in CYP2A6 Activity and personalized medicine. J. Pers. Med. 2017, 7, 18. [Google Scholar] [CrossRef] [PubMed]
- Daly, A.K.; Rettie, A.E.; Fowler, D.M.; Miners, J.O. Pharmacogenomics of CYP2C9: Functional and clinical considerations. J. Pers. Med. 2018, 8, 1. [Google Scholar] [CrossRef] [PubMed]
- Brown, S.-A.; Pereira, N. Pharmacogenomic Impact of CYP2C19 Variation on clopidogrel therapy in precision cardiovascular medicine. J. Pers. Med. 2018, 8, 8. [Google Scholar] [CrossRef] [PubMed]
- Gaedigk, A.; Dinh, J.C.; Jeong, H.; Prasad, B.; Leeder, J.S. Ten years’ experience with the CYP2D6 activity score: A perspective on future investigations to improve clinical predictions for precision therapeutics. J. Pers. Med. 2018, 8, 15. [Google Scholar] [CrossRef] [PubMed]
- Wigle, T.J.; Jansen, L.E.; Teft, W.A.; Kim, R.B. Pharmacogenomics guided-personalization of warfarin and tamoxifen. J. Pers. Med. 2017, 7, 20. [Google Scholar] [CrossRef] [PubMed]
- Aka, I.; Bernal, C.J.; Carroll, R.; Maxwell-Horn, A.; Oshikoya, K.A.; Van Driest, S.L. Clinical pharmacogenetics of cytochrome P450-associated drugs in children. J. Pers. Med. 2017, 7, 14. [Google Scholar] [CrossRef] [PubMed]
- Henderson, L.M.; Claw, K.G.; Woodahl, E.L.; Robinson, R.F.; Boyer, B.B.; Burke, W.; Thummel, K.E. P450 Pharmacogenetics in indigenous North American populations. J. Pers. Med. 2018, 8, 9. [Google Scholar] [CrossRef] [PubMed]
- Pirmohamed, M. Warfarin: The end or the end of one size fits all therapy? J. Pers. Med. 2018, 8, 22. [Google Scholar] [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Rettie, A.E.; Liggett, S.B. Preface to Special Issue on ‘Cytochrome P450 Variation in Pharmacogenomics’. J. Pers. Med. 2018, 8, 23. https://doi.org/10.3390/jpm8030023
Rettie AE, Liggett SB. Preface to Special Issue on ‘Cytochrome P450 Variation in Pharmacogenomics’. Journal of Personalized Medicine. 2018; 8(3):23. https://doi.org/10.3390/jpm8030023
Chicago/Turabian StyleRettie, Allan E., and Stephen B. Liggett. 2018. "Preface to Special Issue on ‘Cytochrome P450 Variation in Pharmacogenomics’" Journal of Personalized Medicine 8, no. 3: 23. https://doi.org/10.3390/jpm8030023